1. Home
  2. Labeler Index
  3. Meridian Medical Technologies Llc
  4. 11704-104
  5. NDC Package Code: 11704-104-01 Atropen Auto-injector

NDC Package 11704-104-01 Atropen Auto-injector

Atropine Injection Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
11704-104-01
Package Description:
.7 mL in 1 SYRINGE, PLASTIC
Product Code:
11704-104
Proprietary Name:
Atropen Auto-injector
Non-Proprietary Name:
Atropine
Substance Name:
Atropine
Usage Information:
The ATROPEN® Auto-Injector is indicated for the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides. The ATROPEN®Auto-Injector should be used by persons who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication. Pralidoxime chloride may serve as an important adjunct to atropine therapy.The ATROPEN®is intended as an initial treatment of the muscarinic symptoms of insecticide or nerve agent poisonings (generally breathing difficulties due to increased secretions); definitive medical care should be sought immediately. The ATROPEN® Auto-Injector should be administered as soon as symptoms of organophosphorous or carbamate poisoning appear (usually tearing, excessive oral secretions, wheezing, muscle fasciculations, etc.). In moderate to severe poisoning, the administration of more than one ATROPEN® may be required until atropinization is achieved (flushing, mydriasis, tachycardia, dryness of the mouth and nose). (See DOSAGE AND ADMINISTRATION) In severe poisonings, it may also be desirable to concurrently administer an anticonvulsant if seizure is suspected in the unconscious individual since the classic tonic-clonic jerking may not be apparent due to the effects of the poison. In poisonings due to organophosphorous nerve agents and insecticides it may also be helpful to concurrently administer a cholinesterase reactivator such as pralidoxime chloride.
11-Digit NDC Billing Format:
11704010401
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
0.7 ML
NDC to RxNorm Crosswalk:
  • RxCUI: 1190536 - atropine sulfate 0.25 MG in 0.3 ML Auto-Injector
  • RxCUI: 1190536 - 0.3 ML atropine sulfate 0.833 MG/ML Auto-Injector
  • RxCUI: 1190536 - atropine sulfate 0.25 MG (atropine 0.21 MG) per 0.3 ML Auto-Injector
  • RxCUI: 1190538 - atropine sulfate 0.5 MG in 0.7 ML Auto-Injector
  • RxCUI: 1190538 - 0.7 ML atropine sulfate 0.714 MG/ML Auto-Injector
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Meridian Medical Technologies Llc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
    • Active Ingredient(s):
  • ATROPINE .5 mg/.7mL
    • Pharmacologic Class(es):
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
  • Cholinergic Muscarinic Antagonist - [EPC] (Established Pharmacologic Class)
  • Cholinergic Muscarinic Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA017106
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-19-2003
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 11704-104-01?

    The NDC Packaged Code 11704-104-01 is assigned to a package of .7 ml in 1 syringe, plastic of Atropen Auto-injector, a human prescription drug labeled by Meridian Medical Technologies Llc. The product's dosage form is injection and is administered via intramuscular form.This product is billed per "ML" milliliter and contains an estimated amount of 0.7 billable units per package.

    Is NDC 11704-104 included in the NDC Directory?

    Yes, Atropen Auto-injector with product code 11704-104 is active and included in the NDC Directory. The product was first marketed by Meridian Medical Technologies Llc on June 19, 2003 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 11704-104-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 0.7.

    What is the 11-digit format for NDC 11704-104-01?

    The 11-digit format is 11704010401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-211704-104-015-4-211704-0104-01